Abstract
Anticoagulant prophylaxis for preventing VTE is a world wide established procedure in hip and knee replacement surgery, as well as in the treatment of femoral neck fractures. Different guidelines are available in literature with quite different recommendations. None of them is a multidisciplinary effort as the one presented. In 2010 the Italian Society on Haemostasis and Thrombosis (SISET), the Italian Society of Orthopaedics and Traumatology (SIOT), the Association of Orthopaedics and Traumatologists of Italian Hospitals (OTODI), together with the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI), have set down practical suggestions for VTE prophylaxis in hip and knee surgery as well as in femoral neck fracture treatment. This Intersociety Consensus Statement aimed at simplifying the grading system reported in the literature, and its goal was to favour its clinical application. Special focuses addressed fragile patients and those patients at high risk of bleeding or receiving chronic antiplatelet and vitamin K antagonists treatment, and a special chapter was dedicated to regional anaesthesia and VTE prophylaxis. The registration of three novel oral anticoagulants (dabigatran, rivaroxaban and apixaban) for VTE prophylaxis in major orthopedic surgery and the ongoing introduction of these drugs for the prevention of embolism in atrial fibrillation make it necessary an update of the Intersociety Consensus Statement.
Similar content being viewed by others
Bibliografia
Geerts WH, Bergqvist D, Pineo GF et al. (2008) Prevention of venous thromboembolism. Chest 133(Suppl):381–453
Falck-Ytter Y, Francis CW, Johanson NA et al. (American College of Chest Physicians) (2012) Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e278–325
Prisco D, Violi F (2002) Linee guida per la profilassi del tromboembolismo venoso in chirurgia ortopedica maggiore: cosa pensa la Società Italiana per lo Studio dell’Emostasi e della Trombosi. Haematologica 87(Suppl 4):11–13
Gruppo di lavoro per le linee guida sul tromboembolismo venoso della Società Italiana per lo Studio dell’Emostasi e della Trombosi (coordinatore D. Prisco) (2003) Linee guida per la diagnosi, la profilassi e la terapia del tromboembolismo venoso. Haematologica 88(Suppl 18):1–61
National Institute for Health and Clinical Excellence (2010) Venous thromboembolism: reducing the risk. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. http://guidance.nice.org.uk/CG92/NICEGuidance/pdf/English
Biggi F, Randelli F, Della Rocca G et al. (2010) Consenso intersocietario sulla profilassi antitrombotica in chirurgia protesica dell’anca e del ginocchio e nelle fratture del collo femorale. Scalpel-OTODI Educ 24:206–211
Randelli F, Biggi F, Della Rocca G et al. (2011) Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery. J Orthop Traumatol 12:69–76
Della Rocca G, Grossi P, Biggi F et al. (2011) Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery. Minerva Anestesiol 77:1003–1010
Biggi F, Randelli F, Romanini E et al. (2012) II consensus intersocietario sulla profilassi antitrombotica in ortopedia e traumatologia. Scalpel-OTODI Educ 26:160–170
Strebel N, Prins M, Agnelli G, Buller HR (2002) Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular weight heparin in elective hip surgery? Arch Intern Med 162:1451–1456
Raskob GE, Hirsh J (2003) Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Chest 124:379S–385S
Turpie AG, Bauer KA, Eriksson BI, Lassen MR (2002) Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a metaanalysis of 4 randomized double-blind studies. Arch Intern Med 162:1833–1840
Eriksson BI, Dahl OE, Rosencher N et al. (2007) Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: randomized, double-blind, non inferiority trial. Lancet 370:949–956
Eriksson BI, Dahl OE, Rosencher N et al. (2007) Oral dabigatran etexilate versus subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement. The RE-MODEL randomized trial. J Thromb Haemost 5:2178–2185
Eriksson BI, Dahl OE, Huo MH et al. (RE-NOVATE II Study Group) (2011) Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II). A randomised, double-blind, non-inferiority trial. Thromb Haemost 105:721–729
Ageno W, Prisco D (2009) La profilassi del tromboembolismo venoso in chirurgia ortopedica maggiore elettiva: il ruolo di dabigatran. Approfondimenti SISET 1/2009
Eriksson BI, Borris LC, Friedman RJ et al. (2008) Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 358:2765–2775
Kakkar AK, Brenner B, Dahl OE et al. (2008) Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet 372:3–9
Lassen MR, Ageno W, Borris RC et al. (2008) Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 358:2776–2786
Turpie AG, Lassen MR, Davidson BL et al. (2009) Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD 4): a randomised trial. Lancet 373:1673–1680
Imberti D, Prisco D (2009) La profilassi del tromboembolismo venoso in chirurgia ortopedica maggiore elettiva: il ruolo di rivaroxaban. Approfondimenti SISET 2/2009
Lassen MR, Raskob GE, Gallus A et al. (2009) Apixaban or enoxaparin for thromboprophylaxis after knee replacement. N Engl J Med 361:594–604
Lassen MR, Raskob GE, Gallus A et al. (2010) Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet 375:807–815
Lassen MR, Gallus A, Raskob GE et al. (2010) Apixaban compared with enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med 363:2487–2498
Raskob GE, Gallus AS, Pineo GF et al. (2012) Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement. Pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 TRIALS. J Bone Jt Surg Br 94:257–264
Imberti D, Gallerani M, Manfredini R (2012) Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery. J Thromb Thrombolysis 34:208–213
Imberti D, Prisco D (2012) La profilassi del tromboembolismo venoso in chirurgia ortopedica maggiore elettiva: il ruolo di apixaban. Approfondimenti SISET 1/2012
Eriksson BI, Quinlan DJ, Eikelboom JW (2011) Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism. Annu Rev Med 62:41–57
Hooker LA, Lachiewicz PF, Kelley SS (1999) Efficacy of prophylaxis against thromboembolism with intermittent pneumatic compression after primary and revision total hip arthroplasty. J Bone Jt Surg Am 81:690–696
Eikelboom JW, Quinlan DJ, Douketis JD (2001) Extended duration prophylaxis against venous thromboembolism after total hip replacement: a meta analysis of the randomised trials. Lancet 358:9–15
Horlocker TT (2001) Low molecular weight heparin and neuraxial anesthesia. Thromb Res 101:141–154
Horlocker TT, Wedel DJ, Rowlingson JC et al. (2010) Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third edition). Reg Anesth Pain Med 35:64–101
Gogarten W, Vandermeulen E, Van Aken H et al. (2010) Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol 27:999–1015
Singelyn FJ, Verheyen CC, Piovella F et al. (2007) The safety and efficacy of extended prophylaxis with fondaparinux after major orthopaedic surgery of the lower limb with or without a neuraxial or deep peripheral nerve catheter: the EXPERT study. Anesth Analg 105:1540–1547
Heidbuchel EH, Verhamme P, Alings M et al. (2013) European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 15:625–651
Conflitto di interessi
Nessuno.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Biggi, F., Randelli, F., Della Rocca, G. et al. Consenso intersocietario sulla profilassi antitrombotica in chirurgia protesica dell’anca e del ginocchio e nelle fratture del collo femorale: aggiornamento 2013. LO SCALPELLO 27, 161–169 (2013). https://doi.org/10.1007/s11639-013-0047-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11639-013-0047-3